The Science of Innovation

Monday, 9 December 2013

mechanism of soliris









Posted by The Science Of Innovation at 10:07
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Blog Archive

  • ►  2014 (2)
    • ►  March (1)
    • ►  February (1)
  • ▼  2013 (13)
    • ▼  December (13)
      • Depofoam Technology; Proprietary Technology of Pac...
      • Acticoat* ; Antimicrobial Barrier Dressing
      • Avastin; angiogenesis inhibitor for chemotherapy
      • ARESTIN®; exhibits synergistic effect with scaling...
      • FDA Approves Abraxane Drug for Pancreatic Cancer
      • DOXIL (doxorubicin hcl liposome injection)
      • IMATINIB in Chronic myeloid leukemia
      • Cancer stem cells; novel target for cancer treatment
      • mechanism of soliris
      • Soliris Soliris® (eculizumab) is a first-in-cl...
      • Gliadel Wafer; FDA approved treatment for brain ca...
      • RNA interference; Novel strategy in treatment of c...
      • Tarceva: targeted therapy for pancreatic cancer

About Me

My photo
The Science Of Innovation
View my complete profile
Simple theme. Theme images by RBFried. Powered by Blogger.